Salvigenin is primarily used in pharmaceutical and biomedical research due to its notable biological activities. It exhibits anti-inflammatory and antioxidant properties, making it a candidate for development in treatments for chronic inflammatory diseases and oxidative stress-related conditions. Studies suggest potential anticancer effects, where salvigenin has shown the ability to inhibit the growth of certain tumor cells by inducing apoptosis and cell cycle arrest. It is also being explored for neuroprotective applications, particularly in models of neurodegenerative disorders like Alzheimer’s disease, owing to its capacity to cross the blood-brain barrier and reduce neuronal damage. Additionally, salvigenin demonstrates antimicrobial activity against select pathogens, supporting its traditional use in herbal medicine. Its role as a bioactive scaffold also makes it valuable in designing derivatives for drug discovery.